p53-Dependent Signal Transduction Induced by Stress

Journal of Radiation Research

Volumn 38, Issue 3, 1997, Pages 179-194

  Wang, Xinjiang ^a   Ohnishi, Takeo ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cancer evolution; p53; Signal transduction; Stress

Indexed keywords

BACTERIOPHAGES; CELL DEATH; CELL SIGNALING; CROSSTALK; DISEASES; MAMMALS; ONCOGENIC VIRUSES; SIGNAL TRANSDUCTION;

CANCER EVOLUTION; CELLULAR STRESS RESPONSE; ENZYME SUBSTRATES; GENOTOXIC AGENTS; GENOTOXIC STRESS; MAMMALIAN CELLS; MOLECULAR DISSECTION; P53; PROTO-ONCOGENES; SIGNALING NETWORKS;

SIGNALING;

MAMMALIA;

ANIMAL; APOPTOSIS; DNA REPAIR; GENE EXPRESSION REGULATION; HUMAN; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; STRESS; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; SIGNAL TRANSDUCTION; STRESS;

EID: 0031216384     PISSN: 04493060     EISSN: None     Source Type: Journal    
DOI: 10.1269/jrr.38.179     Document Type: Article

References (135)

1. Ames, B.N., Gold, L.S. and Willett, W.C. (1995) The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA 92: 5258-5265.
2. Morimoto, R.I. (1993) Cell in stress: transcriptional activation of heat shock genes. Science 259: 1409-1410.
3. Canman, C.E. and Kastan, M.B. (1996) Three paths to stress relief. Nature 384: 213-214.
4. Kastan, M., Zhan, Q., El-Deiry, W., Carrier, F., Jacks, T., Walsh, W., Plunkett, B., Vogelstein, B. and Fornance, A. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71: 587-597.
5. Lu, X. and Lane, D. (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosome instability syndromes? Cell 75: 765-778.
6. 2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 10: 2263-2270.
7. Weinert, T.A. and Hartwell, L.H. (1988) The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevsiae. Science 241: 317-322.
8. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14: 6264-6277.
9. Ohnishi, T., Wang, X., Ohnishi, K., Matsumoto, H. and Takahashi, A. (1996). p53-dependent induction of WAF1 by heat treatment in human glioblastoma cells. J. Biol. Chem. 271: 14510-14513.
10. Ohtsubo, T., Wang, X., Takahashi, A., Ohnishi, K., Saito, H. Song, C.W. and Ohnishi, T. (1997) p53-dependent Induction of WAF1 by Low pH Culture Condition in Human Glioblastoma Cells. Cancer Res. 57: 3910-3913.
11. Sugano, T., Nitta, M., Ohmori, H. and Yamaizumi, M. (1995) Nuclear accumulation of p53 in normal human fibroblasts is induced by various cellular stresses which evoke the heat shock response independent of cell cycle. Jpn. J. Cancer Res. 86: 415-418.
12. Dutta, A., Ruppert, J., Aster, J. and Winchester, H. (1993) Inhibition of DNA replication factor RPA by p53. Nature 365: 79-82.
13. Barak, Y. and Oren, M. (1992) Binding of a 95kD protein is correlated with wild-type p53 activity. EMBO J. 11: 2115-2121.
14. Ehrhart, J.C., Duthu, A., Ullrich, S., Appella, E. and May, P. (1988) Specific interaction between a subset of the p53 protein family and heat shock proteins hsp72/hsp73 in human osteosarcoma cell lines. Oncogene 3: 595-603.
15. Iwabuchi, K., Bartel, P.L., Li, B., Marraccino, R. and Fields, S. (1994) Two cellular proreins that bind to wild-type but not mutant p53. Proc. Natl. Acad. Sci. USA 91: 6098-6102.
16. Truant, R., Xiao, H., Ingles, C.J. and Greenblatt, J. (1993) Direct interaction between the transcriptional activation domain of human p53 and the TATA-box-binding protein. J. Biol. Chem. 268: 2284-2287.
17. Wang, X.W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J.M., Wang, Z., Friedberg, E.C., Evans, M.K., Taffe, B.G., Bohr, V.A., Weeda, G., Hoeijmakers, J.H., Forrester, K. and Harris, C.C. (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet. 10: 188-194.
18. Maheswaran, S., Englert, C., Bennet, P., Heinrich, G. and Haeber, D.A. (1995) The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes & Dev. 9: 2143-2156.
19. Sfrensen, T.S., Girling, R., Lee, C.W., Gannon, J., Bandara, L.R. and Thangue, N.B. (1996) Functional interaction between DP-1 and p53. Mol. Cell. Biol. 16: 5888-5895.
20. Sturzbecher, H., Donzelmann, B., Henning, W., Knippschild, U. and Buchhop, S. (1996) p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J. 15: 1992-2002.
21. Harlow, E., Pim, D.C. and Crawford, L.V. (1981) Complex of simian virus 40 large-T antigen and host 53, 000-molecular-weight protein in monkey cells. J. Virol. 37: 564-573.
22. Sarnow, P., Ho., Y.S., Willium, J. and Levine, A.J. (1982) Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54kd cellular protein in transformed cells. Cell 28: 387-394.
23. Werness, B.A., Levine, A.J. and Howley, P.M. (1990) Association of human papillomavirus type16 and 18 E6 protein with p53. Science 248: 76-79.
24. Wang, X.W., Forrester, K., Yeh, H., Feitelson, M.A., Gu, J.R. and Harris, C.C. (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. USA 91: 2230-2234.
25. Oren, M. and Prives, C. (1996) p53: upstream, downstream and off stream, review of the 8th p53 workshop (Dundee, July 5-9, 1996). Biochim. Biophys. Acta, 1288: R13-R19.
26. Gottlieb, T.M. and Oren, M.(1996) p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287: 77-102.
27. Smith, M.L., Kontny, H.U., Zhan, Q., Sreenath, A., O'Connor, P.M. and Fornace, J.A. (1996) Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin. Oncogene 13: 2255-2263.
28. Miyashita, T. and Reed, J.C. (1995) Tumor-suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 80: 293-299.
29. Owen-schaub, L.B., Zhang, W., Cusack, J.C., Angelo, L.S., Santee, S.M., Fujiwara, T., Roth, J.A., Deisseroth, A.B., Zhang, W.W., Kruzel, E. and Radinsky, R. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 Expression. Mol. Cell. Biol. 15: 3032-3040.
30. Okamoto, K. and Beach, D. (1994) Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13: 4816-4822.
31. Zhao, J., Schmieg, F.I., Logsdon, N., Freedman, D., Simmons, D.T. and Molloy, G.R. (1996) p53 binds to a novel recognition sequence in the proximal promoter of the rat muscle creatine kinase gene and activates its transcription. Oncogene 13: 293-302.
32. Dameron, K.M., Volpert, O.V., Tainsky, M.A. and Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584.
33. Mukhopadhyay, D., Tsiokas, L. and Sukhatme, V.P. (1995) Wild-type p53 and v-Src exert opposing influence on human vascular endothelial growth factor gene expression. Cancer Res. 55: 6161-6165.
34. Buckbinder, L., Talbott, R., Velasco-Miguel, S., Takenaka, I., Faha, B., Seizinger, B.R. and Kley, N. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649.
35. Rouault, J.P., Falette, N., Guehenneux, F., Guillot, C., Rimokh, R., Wang, Q., Berthet, C., Moyret-Lalle, C., Savatier, P., Pain, B., Shaw, P., Berger, R., Samarut, J., Magaud, J.P., Ozturk, M., Samarut, C. and Puisieux, A. (1996) Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nature Genet. 14: 482-496.
36. Forrester, K., Ambs, S., Lupold, S.E., Kapust, R.B., Spillare, E.A., Weinberg, W.C., Felley-Bosco, E., Wang, X.W., Geller, D.A., Tzeng, E., Billiar, T.R. and Harris, C.C. (1996) Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. USA 93: 2442-2447.
37. Ginsberg, D., Mechta, F., Yaniv, M. and Oren, M. (1991) Wild type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA 88: 9979-9983.
38. Seto, E., Usheva, A., Zambetti, G.P., Momand, J., Horikoshi, N., Weinmann, R., Levine, A.J. and Shenk, T. (1992) Wild-type p53 binds to the TATA-box-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 89: 12028-12032.
39. Farmer, G., Friedlander, P., Colgan, J., Manley, J.L. and Prives, C. (1996) Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein. Nucl. Acids. Res. 24: 4281-4288.
40. Santhanam, U., Ray, A. and Sehgal, P.B. (1991) Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 88: 7605-7609.
41. Ueba, T., Nosaka, T., Takahashi, J.A., Shibata, F., Florkiewicz, R.Z., Vogelstein, B., Oda, Y., Kikuchi, H. and Hatanaka, M. (1994) Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells. Proc. Natl. Acad. Sci. USA 91: 9009-9013.
42. Kley, N., Chung, R.Y., Fay, S., Loeffler, J.P. and Seizinger, B.R. (1992) Repression of the basal c-fos promoter by wild-type p53. Nucl. Acids. Res. 20: 4083-4087.
43. Chin, K.V., Ueda, K., Pastan, I. and Gottesman, M.M. (1992) Modulation of the activity of the promoter of the human MDR1 gene by Ras and p53. Science 255: 460-462.
44. 1 phase. Proc. Natl. Acad. Sci. USA 89: 9210-9214.
45. Mercer, W.E., Shields, M.T., Lin, D., Appella, E. and Ullrich, S.J. (1991) Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc. Natl. Acad. Sci. USA 88: 1958-1962.
46. Agoff, S., Hou, J., Linzer, D. and Wu, B. (1993) Regulation of the human hsp70 promoter by p53. Science 259: 84-87.
47. Murphy, M., Hinman, A. and Levine, A.J. (1996) Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes & Dev. 10: 2971-2980.
48. Sandri, M.I., Isaacs, R.J., Ongkeko, W.M., Harris, A.L., Hickson, I.D., Broggini, M. and Vikhanskaya, F. (1996) p53 regulates the minimal promoter of the human topoisomerase IIα gene. Nucl. Acids Res. 24: 4464-4470.
49. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
50. 1 cyclin-dependent kinases. Cell 75: 805-816.
51. Chellappan, S.P., Hiebert, S.W., Mudryl, M., Horowitz, J.M. and Nevins, J.R. (1991) The E2F transcription factor is a cellular target for Rb protein. Cell 65: 1053-1061.
52. Hiebert, S.W., Chellappan, S.P., Horowitz, J.M. and Nevins, J.R. (1992) The interaction of Rb with E2F coincides with the transcriptional activity of E2F. Genes & Dev. 4: 177-185.
53. Bartek, J., Bartkova, J. and Lukas, J. (1996) The retinoblastoma protein pathway and the restriction point, Curr. Opin. Cell. Biol. 8: 805-814.
54. Waga, S., Hannon, G.J., Beach, D. and Stillman, B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-577.
55. Prelich, G., Tan, C.K., Kostura, M., Mathews, M.B., So, A.G., Downney, K.M. and Stillman, B. (1987) Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326: 517-520.
56. Bambara, R.A. and Jessee, C.B. (1991) Properties of DNA polymerase δ and ε, and their roles in eukaryotic DNA replication. Biochim Biophys Acta 1088: 11-14.
57. Lane, D. (1992) p53, guardian of the genome. Nature 358: 15-16.
58. Mummenbrauer, T., Janus, F., Muller, B., Wiesmuller, L., Deppert, W. and Grosse, F. (1996) p53 protein exhibits 3′-to-5′ exonuclease activity. Cell 85: 1089-1099.
59. Lee, S., Elenbaas, B., Levine, A. and Griffith, J. (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81: 1013-1020.
60. Bakalkin, G., Yakovleva, T., Selivanova, G., Magnusson, K., Szekely, L., Kiseleva, E., Klein, G., Terenius, L. and Wiman, K. (1994) p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Natl. Acad. Sci. USA 91: 413-417.
61. Wang, X.W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J.M., Wang, Z., Friedberg, E.C., Evans, M.K., Taffe, B.G., Bohr, V.A., Weeda, G., Hoeijmakers, J.H., Forrester, K. and Harris, C.C. (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet. 10: 188-194.
62. 6-methylguanine DNA methyltransferase gene. Cancer Res. 56: 2029-2032.
63. Ishizaki, K., Ejima, Y., Matsunaga, T., Hara, R., Sakamoto, A., Ikenaga, M., Ikawa, Y. and Aizawa, S. (1994) Increased UV-induced SCEs but normal repair of DNA damage in p53-deficient mouse cells. Int. J. Cancer 58: 254-257.
64. Sands, A.T., Suraokar, M.B., Sanchez, A., Marth, J.E., Donehower, L.A. and Bradley, A. (1995) p53 deficiency does not affect the accumulation of point mutation in a transgene target. Proc. Natl. Acad. Sci. USA 92: 8517-8521.
65. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. and Oren, M. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347.
66. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
67. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. and Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and p53-independent pathways. Nature 362: 849-852.
68. Lotem, J. and Sachs, L. (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 83: 1092-1096.
69. Attardi, L.D., Lowe, S.W., Brugarolas, J. and Jacks, T. (1996) Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15: 3693-3701.
70. Sabbatini, P., Lin, J., Levine, A.J. and White, E. (1995) Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes & Dev. 9: 2184-2192.
71. Desaintes, C., Demeret, C., Goyat, S., Yaniv, M. and Thierry, F. (1997) Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J. 16: 504-514.
72. Caelles, C., Helmberg, A. and Karin, M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370: 220-223.
73. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K.H. and Oren, M. (1995) Induction of apoptosis in HeLa cells by trans-activation deficient p53. Genes & Dev. 9: 2170-2183.
74. L depends on normal p53 function. Oncogene 13: 2287-2293.
75. Haldar, S., Negrini, M., Monne, M., Sabbioni, S. and Croce, C.M. (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 54: 2095-2097.
76. Selvakumaran, M., Lin, H., Miyashita, T., Wang, H., Krajewski, S., Reed, J., Hoffman, B. and Liebermann, D. (1994) Immediate early up-regulation of Bax expression by p53 but not TGFβ1: A paradigm for distinct apoptotic pathways. Oncogene 9: 1791-1798.
77. Zhan, Q., Fan, S., Bae, I., Guillouf, C., Liebermann, D.A., O'Connor, P.M. and Fornace, A.J. Jr. (1994) Induction of Bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9: 3743-3751.
78. Fanidi, A.E., Harrington, A. and Evan, G. (1992) Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554-556.
79. Chiou, S.K., Rao, L. and White, E. (1994) Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14: 2556-2563.
80. Nunez, G., London, L., Hockenbery, D., Alexander, M., Mckearn, J.P. and Korsmeyer, S.J. (1990) Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144: 3602-3610.
81. Dole, M., Nunez, G., Merchant, A.K., Maybaum, J., Rode, C.K., Bloch, C.A. and Castle, V.P. (1994) Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54: 3253-3259.
82. Oltvai, Z.N., Milliman, C.L. and Korsmeyer, S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74: 609-619.
83. Korsmeyer, S.J., Shutter, J.R., Veis, D.J., Merry, D.E. and Oltvai, Z.N. (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death, Semin. Cancer Biol. 4: 327-332.
84. Hale, A., Smith, C.A., Sutherland, L.C., Stoneman, V.E., Longthorne, V.L., Culhane, A.C. and Williams, G.T. (1996) Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236: 1-26.
85. Sellins, K.S. and Cohen, J.J. (1987) Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139: 3199-3206.
86. Radford, I.R. (1994) Radiation response of mouse lymphoid and myeloid cell lines. Part I. Sensitivity to killing by ionizing radiation, rate of loss of viability, and cell type of origin. Int. J. Radiat. Biol. 65: 203-215.
87. Radford, I.R. (1994) p53 status, DNA double-strand break repair proficiency, and radiation response of mouse lymphoid and myeloid cell lines. Int. J. Radiat. Biol. 66: 557-560.
88. Yamada, T. and Ohyama, H. (1988) Radiation-induced interphase death of rat thymocytec is internally programmed (apoptosis). Int. J. Radiat. Biol. 53: 65-75.
89. Potten, C.S. (1977) Extreme sensitivity of some intestinal crypt cells to X and γ-irradiation. Nature 269: 518-520.
90. Clarke, A.R., Gledhill, S., Hooper, M.L., Bird, C.C. and Wyllie, A.H. (1994) p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 9: 1767-1773.
91. Gobe, G.C., Axelsen, R.A., Harmon, B.V. and Allan, D.J. (1988) Cell death by apoptosis following X-irradiation of the foetal and neonatal rat kidney. Int. J. Radiat. Biol. 54: 567-576.
92. Stephens, L.C., Ang, K.K., Schultheiss, T.E., Milas, L. and Meyn, R.E. (1991) Apoptosis in irradiated murine tumors. Radiat. Res. 127: 308-316.
93. Miller, E.M. and Kinsella, T.J. (1992) Radiosensitization by fluorodeoxyuridine: effects of thymidylate synthase inhibition and cell synchronization. Cancer Res. 52: 1687-1694.
94. McGinn, C.J., Miller, E.M., Lindstrom, M.J., Kunugi, K.A., Johnston, P.G. and Kinsella, T.J. (1994) The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoyuridine radiosensitization. Int. J. Radiat. Oncol. Biol. Phys. 30: 851-859.
95. 1 checkpoint control. Cell 82: 675-684.
96. Polyak, K., Waldman, T., He, T.C., Kinzler, K.W. and Vogelstein, B. (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes & Dev. 10: 1945-1952.
97. Jamal, S. and Ziff, E.B. (1995) Raf-1 phosphorylates p53 in vitro and potentiates p53-dependent transcriptional transactivation in vivo. Oncogene 10: 2095-2101.
98. INK4. Cell 88: 593-602.
99. Price, B.D. and Youmell, M.B., (1996) The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Cancer Res. 56: 246-250.
100. Meyn, M.S. (1995) Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res. 55: 5591-6001.
101. Houldsworth, J. and Levin, M.F. (1980) The effect of ionizing radiation on DNA synthesis in ataxia-telangiectasia cells. Nucl. Acids Res. 8: 3709-3720.
102. Beamish, H. and Lavin, M.F. (1994) Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int. J. Radiat. Biol. 65: 175-184.
103. Xu, Y. and Baltimore, D. (1996) Dual role of ATM in the cellular response to radiation and in cell growth control. Genes & Dev. 10: 2401-2410.
104. Lakin, N.D., Weber, P., Stankovic, T., Rottinghaus, S.T., Taylor, A.M. and Jackson, S.P. (1996) Analysis of the ATM protein in wild-type and ataxia telangiectasia cells. Oncogene 13: 2707-2716.
105. Wu, H. and Lozano, G. (1994) NF-κB activation of p53. J. Biol. Chem. 269: 20067-20074.
106. Perkins, N.D., Felzien, L.K., Betts, J.C., Leung, K., Beach, D.H. and Nabel, G.J. (1997) Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275: 523-525.
107. Jung, M., Zhang, Y., Lee, S. and Dritschilo, A. (1995) Correction of radiation sensitivity in ataxia-telangiectasia cells by a truncated IκB-α. Science 268: 1619-1621.
108. Datto, M.B., Li, Y., Panus, J.F., Howe, D.J., Xiong, Y. and Wang, X.F. (1995) Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92: 5545-5549.
109. Rosette, C. and Karin, M. (1996) Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274: 1194-1197.
110. Kharbanda, S., Saleem., A., Shafman, T., Emoto, Y., Taneja, N., Rubin, E., Weichselbaum, R., Woodgett, J., Avruch, J., Kyriakis, J. and Kufe, D. (1995) Ionizing radiation stimulates a Grb2-mediated association of the stress-activated protein kinase with phosphatidylinositol 3-kinase. J. Biol. Chem. 270: 18871-18874.
111. Urich, M., El Shemerly, M.Y.M., Besser, D., Nagamine, Y. and Ballmer-Hofer, K. (1995) Activation and nuclear translocation of mitogen-activated kinase by polyomavirus middle-T or serum depend on phosphatidylinositol 3-kinase. J. Biol. Chem. 270: 29286-29292.
112. Matsumoto, H., Hayashi, S., Shioura, H., Ohtsubo, T., Ohnishi, T. and Kano, E. (1996) Suppression of heat-induced hsp accumulation by cisplatin in human glioblastoma cells. Cancer Lett. 110: 253-257.
113. Wang, X., Takahashi, A., Ohnishi, K., Matsumoto, H., Suda, K. and Ohnishi, T. (1997) Bifunctional effects of a protein kinase inhibitor (H-7) on heat-induced p53-dependent WAF1 accumulation. Exp. Cell Res. in press.
114. Fornace, A.J. Jr. (1992) Mammalian genes induced by radiation; activation of genes associated with growth control. Annu. Rev. Genet. 26: 507-526.
115. Gewirtz, D.A. (1993) DNA damage, gene expression, growth arrest and cell death. Oncol. Res. 5: 397-408.
116. Evans, G., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. and Hancock, D.C. (1992) Induction of apoptosis in fibroblasts by c-Myc proteins. Cell 69: 119-128.
117. Harrington, E.A., Bennett, M.R., Fanidi, A. and Evan, G.I. (1994) c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13: 3286-3295.
118. Fuks, Z., Persaud, R.S., Alfieri, A., MclLoughlin, M., Ehleiter, D., Schwartz, J.L., Seddon, A.P., Cordon-Cardo, C. and Haimovitz-Friedman, A. (1994) Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 54: 2582-2590.
119. Haimovitz-Friedman, A., Balaban, N., MclLoughlin, M., Ehleiter, D., Michaeli, J., Vlodavsky, I. and Fuks, Z. (1994) Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. 54: 2591-2597.
120. Packham, G. and Cleveland, J.L. (1995) c-Myc and apoptosis. Biochim. Biophys. Acta 1242: 11-28.
121. Hermeking, H. and Eick, D. (1994) Mediation of c-myc-induced apoptosis by p53. Science 265: 2091-2093.
122. waf1/cip1. Genes & Dev. 8: 2817-2830.
123. Lotem, J. and Sachs, L. (1993) Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth & Diff. 4: 41-47.
124. Sala, A., Casella, I., Grasso, L., Bellon, T., Reed, J.C., Miyashita, T. and Peschle, C. (1996) Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-Myb and the growth suppressor p53. Cancer Res. 56: 1991-1996.
125. Nevins, J.R. (1992) E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258: 424-428.
126. Qin, X.Q., Livingston, D.M., Kaelin, W.G.J. and Adams, P.D. (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91: 10918-10922.
127. Wu, X. and Levine, A.J. (1994) p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91: 3602-3606.
128. Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G.Jr., Livingston, D.M., Orkin, S.H. and Greenberg, M.E. (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561.
129. Preston, G.A., Lyon, T.T., Yin, Y., Lang, J.E., Solomon, G., Annab, L., Srinivasan, D.G., Alcorta, D.A. and Barrett, J.C. (1996) Induction of apoptosis by c-Fos protein. Mol. Cell Biol. 16: 211-218.
130. Almasan, A., Yin, Y., Kelly, R.E., Lee, E.Y., Bradley, A., Li, W., Bertino, J.R. and Wahl, G.M. (1995) Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc. Natl. Acad. Sci. USA 92: 5436-5440.
131. Kondo, S. (1995) Apoptosis by antitumor agents and other factors in relation to cell cycle checkpoints. J. Radiat. Res. 36: 56-62.
132. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, Butel J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215-221.
133. Norimura, T., Nomoto, S., Katsuki, M., Gondo, Y. and Kondo, S. (1996) p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nature Med. 2: 577-580.
134. Guidos, C.J., Williams, C.J., Grandal, I., Knowles, G., Huang, M.T. and Danska, J.S. (1996) V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes & Dev. 10: 2038-2054.
135. Santana, P., Pena, LA., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, EH., Fuks, Z. and Kolesnick, R. (1996) Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86: 189-199.